Alice Zhang, 29
Traditional approaches to drug development for diseases like Alzheimer’s, Parkinson’s, and amyotrophic lateral sclerosis (ALS) haven’t offered patients much. Alice Zhang is trying something new. Her company, Verge Genomics, uses artificial intelligence to identify promising compounds, refining the algorithms with high-quality data from patients and lab tests. She hopes this will be a more effective way to find treatments for intractable neurodegenerative diseases.
Read more on technologyreview.com.